Clearbridge Health to list on Catalist; seeking to raise $24.6 million

SINGAPORE (Dec 11): Clearbridge Health has announced an initial public offering to list on the Singapore Exchange (SGX) Catalist Board with an invitation issue of 88 million shares at 28 cents each, to raise $24.6 million.

This issue represents approximately 18.3% of the enlarged share capital of 481 million shares of Clearbridge, bringing its market capitalisation post listing to approximately $134.7 million.

Clearbridge formerly ran an accelerator programme to incubate and accelerate healthcare technology start-ups, managing a $40 million fund to invest in life-sciences companies under the SPRING Singapore Biomedical Sciences Accelerator programme, before pivoting and renaming itself Clearbridge Health.

---

Related Stories

• SGX enjoys FX, iron ore derivatives boost in 1HFY2024; insists spac rules 'work'
• Familiar names such as Reddit throw their hats in 2024 IPO market revival ring
• Pegasus Asia to dissolve its spac. Will Novo Tellus follow suit? (update)

---